BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24145605)

  • 1. Truncation of gene F5L partially masks rescue of vaccinia virus strain MVA growth on mammalian cells by restricting plaque size.
    Dobson BM; Tscharke DC
    J Gen Virol; 2014 Feb; 95(Pt 2):466-471. PubMed ID: 24145605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice.
    Dobson BM; Procter DJ; Hollett NA; Flesch IE; Newsome TP; Tscharke DC
    Virology; 2014 May; 456-457():145-56. PubMed ID: 24889234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
    Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
    J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
    Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
    Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
    Peng C; Moss B
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
    Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
    J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.
    Sperling KM; Schwantes A; Staib C; Schnierle BS; Sutter G
    J Virol; 2009 Jun; 83(12):6029-38. PubMed ID: 19357172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants.
    Melamed S; Wyatt LS; Kastenmayer RJ; Moss B
    Vaccine; 2013 Sep; 31(41):4569-77. PubMed ID: 23928462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
    Meyer H; Sutter G; Mayr A
    J Gen Virol; 1991 May; 72 ( Pt 5)():1031-8. PubMed ID: 2033387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of recombinant MVA by rescue of the essential D4R gene.
    Ricci PS; Schäfer B; Kreil TR; Falkner FG; Holzer GW
    Virol J; 2011 Dec; 8():529. PubMed ID: 22152060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
    Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J
    J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
    Backes S; Sperling KM; Zwilling J; Gasteiger G; Ludwig H; Kremmer E; Schwantes A; Staib C; Sutter G
    J Gen Virol; 2010 Feb; 91(Pt 2):470-82. PubMed ID: 19846675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.
    Liu R; Mendez-Rios JD; Peng C; Xiao W; Weisberg AS; Wyatt LS; Moss B
    PLoS Pathog; 2019 May; 15(5):e1007710. PubMed ID: 31145755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.
    Meisinger-Henschel C; Schmidt M; Lukassen S; Linke B; Krause L; Konietzny S; Goesmann A; Howley P; Chaplin P; Suter M; Hausmann J
    J Gen Virol; 2007 Dec; 88(Pt 12):3249-3259. PubMed ID: 18024893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.
    Wyatt LS; Xiao W; Americo JL; Earl PL; Moss B
    mBio; 2017 Jun; 8(3):. PubMed ID: 28588133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1.
    Zhu J; Gao X; Li Y; Zhang Z; Xie S; Ren S; Li Y; Li H; Niu K; Fu S; Deng Y; Li Y; Moss B; Wu W; Peng C
    Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2304242120. PubMed ID: 37607234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling.
    Price PJ; Torres-Domínguez LE; Brandmüller C; Sutter G; Lehmann MH
    Vaccine; 2013 Sep; 31(39):4231-4. PubMed ID: 23523404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA).
    Jordan I; Horn D; Thiele K; Haag L; Fiddeke K; Sandig V
    Virol Sin; 2020 Apr; 35(2):212-226. PubMed ID: 31833037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
    Chahroudi A; Garber DA; Reeves P; Liu L; Kalman D; Feinberg MB
    J Virol; 2006 Sep; 80(17):8469-81. PubMed ID: 16912297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of Genes by Frameshift Mutations Provides Rapid Adaptation of an Attenuated Vaccinia Virus.
    Senkevich TG; Zhivkoplias EK; Weisberg AS; Moss B
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32669330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.